| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Brazil | 2 | |
| #2 | Canada | 2 | |
| #3 | China | 2 | |
| #4 | EPO (European Patent Office) | 2 | |
| #5 | Republic of Korea | 2 | |
| #6 | Mexico | 2 | |
| #7 | United States | 2 | |
| #8 | WIPO (World Intellectual Property Organization) | 2 | |
| #9 | Australia | 1 | |
| #10 | Israel | 1 | |
| #11 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Heterocyclic compounds | |
| #3 | Therapeutic chemical compounds | |
| #4 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Dai Xing | 13 |
| #2 | Wang Yaolin | 13 |
| #3 | Yaolin Wang | 5 |
| #4 | Xing Dai | 5 |
| Publication | Filing date | Title |
|---|---|---|
| MX2018009633A | Inhibitor of indoleamine-2,3-dioxygenase (ido). | |
| CN109362222A | Selective estrogen receptor degradation product and application thereof |